Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Surgery Partners (SGRY) over the last 11 years, with Q3 2025 value amounting to -$5.1 million.

  • Surgery Partners' Other Operating Expenses fell 92000.0% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.3 million, marking a year-over-year decrease of 32941.18%. This contributed to the annual value of $800000.0 for FY2024, which is 10754.72% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Other Operating Expenses is -$5.1 million, which was down 92000.0% from -$2.2 million recorded in Q1 2025.
  • Surgery Partners' Other Operating Expenses' 5-year high stood at $32.8 million during Q1 2022, with a 5-year trough of -$5.1 million in Q3 2025.
  • Over the past 4 years, Surgery Partners' median Other Operating Expenses value was -$2.2 million (recorded in 2025), while the average stood at $1.1 million.
  • Per our database at Business Quant, Surgery Partners' Other Operating Expenses soared by 16000.0% in 2024 and then plummeted by 92000.0% in 2025.
  • Over the past 4 years, Surgery Partners' Other Operating Expenses (Quarter) stood at -$3.5 million in 2022, then increased by 28.57% to -$2.5 million in 2023, then soared by 80.0% to -$500000.0 in 2024, then crashed by 920.0% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$2.2 million for Q1 2025, and -$500000.0 during Q3 2024.